SCHEDULE 13D/A Filed 2026-08-18 Event 2026-08-14 SEC 0001104659-26-098152 →

→ HUMACYTE, INC. HUMAW

Stake: 4.90% Shares: 13,603,235 CUSIP: 020751103 Class: Common Stock, par value $0.0001 per share

Item 4 — Purpose of Transaction

Not extracted from this filing — typically because it's an amendment (13D/A) and Item 4 is unchanged from the parent filing. Read the raw SEC filing →

Cross-References

Insider Activity (last 365d)

0 transactions

0 buys · 0 sales · 0 awards/exercises

Issuer Cluster

7 13D/G filings on this issuer

6 other filings besides this one

Filer Track Record

4 filings by this filer

3 other filings in the data moat

Short Interest · settle 2026-07-31

DTC 1.00

3,071 shares short · -18.1% vs prior

Other 13D/G Filings on HUMACYTE, INC.

Filed	Form	Filer	Stake	Shares
2026-07-13	SCHEDULE 13D/A	FRESENIUS MEDICAL CARE HOLDINGS INC /NY/	6.80%	18,312,735	view →
2026-06-22	SCHEDULE 13G	DAVIDSON KEMPNER CAPITAL MANAGEMENT LP	—	—	view →
2026-06-15	SCHEDULE 13D/A	FRESENIUS MEDICAL CARE HOLDINGS INC /NY/	—	18,312,735	view →
2026-01-09	SCHEDULE	Fresenius Medical Care AG	9.50%	18,312,735	view →
2024-11-18	SC	FRESENIUS MEDICAL CARE HOLDINGS INC /NY/	—	—	view →
2022-09-19	SC	Niklason Laura E	—	—	view →

Other Filings by FRESENIUS MEDICAL CARE HOLDINGS INC /NY/

Filed	Form	Issuer	Stake	Shares
2026-07-13	SCHEDULE 13D/A	HUMACYTE, INC.	6.80%	18,312,735	view →
2026-06-15	SCHEDULE 13D/A	HUMACYTE, INC. HUMAW	—	18,312,735	view →
2024-11-18	SC	Humacyte, Inc. HUMAW	—	—	view →

Want this depth on every filing the moment it hits SEC EDGAR?

Full feed access · API · daily intelligence brief · custom alerts. From $49/mo.

See pricing →